• 09 May 23

Eden Research reports strong sales recovery for 2022, with significant opportunities still ahead

Eden Research reports strong sales recovery for 2022, with significant opportunities still ahead

Eden Research plc | EDEN | 3.8 0 0%

    • 92 views

 

Eden Research PLC (AIM:EDEN, OTCQB:EDNSF) CEO Sean Smith tells Proactive's Stephen Gunnion a strong recovery in the European wine grape market has boosted demand for the company's plant-derived biofungicide Mevalone as farmers return to pre-pandemic levels of pesticide applications.

Smith discussed the company's result for the year to December 31, 2022, as well as the factors that are likely to support growth in 2023, including regulatory approval for products in the US and new product lines that are nearing commercialisation.

The commercial launch of products in the US presents a substantial opportunity, he added.

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Eden Research CEO says new regulatory approval expands Spanish market for key biofungicide

Companies: Eden Research plc

Eden Research CEO hails product approvals in Italy and Spain for organic farming

Companies: Eden Research plc

Eden Research recently attained regulatory approval in California for Mevalone

Companies: Eden Research plc

Eden Research gets 'emergency use' green light for Mevalone in France

Companies: Eden Research plc

Eden Research targets New Zealand wine grape market after receiving regulatory sign-off

Companies: Eden Research plc

Eden Research says 'good first half is encouraging sign' as company gets set for busy period

Companies: Eden Research plc

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top